previous  ...10111213141516171819...  next  · entire list

Embracing Alternative Care
2008-01-09, U.S. News and World Report
http://health.usnews.com/articles/health/2008/01/09/embracing-alternative-car...

"To be blunt, if my wife and I didn't think it was helping him, we wouldn't have continued with it," says Dan Polley. He's talking about Mikey, the Polleys' 2½-year-old in the next room, who was diagnosed with acute lymphocytic leukemia when he was 6 months old. Chemotherapy, radiation, and a bone marrow transplant have been crucial elements of Mikey's treatment. But the "it" his father speaks of is nothing like these aggressive, costly, and heavily researched exemplars of western care -— it is a kind of touch therapy. Gentle and benign, "healing touch" is intended to rebalance the energy field that its practitioners believe surrounds the body and flows through it along defined pathways, affecting health when disrupted. Several times a week, therapist Lynne Morrison spends 20 minutes unblocking and smoothing Mikey's energy field, which energy healers like Morrison say they can feel and correct. The setting for the unorthodox therapy ... would have been startling just five or 10 years ago. Morrison is on the staff of Children's Memorial Hospital in Chicago, a ... research-oriented emblem of western medicine. It perennially ranks among America's premier hospitals. And Mikey is only one of many children there receiving care that not long ago was called alternative medicine. Now it is more often called CAM, for complementary and alternative medicine, or integrative medicine, to avoid the loaded "alternative." The message the new labels are meant to convey is that the therapies more often go hand in hand with traditional medicine than substitute for it.

Note: For lots of exciting reports on new health research, click here.

Drug makers spend more on marketing than research: study
2008-01-03, CBC News (Canada's equivalent of PBS)
http://www.cbc.ca/consumer/story/2008/01/03/drugs.html

U.S. drug companies spend almost twice as much on marketing and promoting medications [as] on research and development, a new Canadian study says. "These numbers clearly show how promotion predominates over R&D in the pharmaceutical industry, contrary to the industry's claim," the authors write in this week's peer-reviewed journal Public Library of Science Medicine. Using data from two market research companies, the University of Quebec's Marc-André Gagnon and York University's Joel Lexchin found U.S. drug companies spent $57.5 billion US on promotional activities in 2004 compared with $31.5 billion on research and development. Promotional activities included free samples, visits from drug reps, direct-to-consumer advertising of drugs, meetings with doctors to promote products, e-mail promotions, direct mail and clinical trials designed to promote the prescribing of new drugs rather than to generate scientific data. The authors say their figure of $57.5 billion US is likely an underestimate, citing other avenues for promotion such as ghostwriting of articles in medical journals by drug company employees, or the off-label promotion of drugs. Drug companies have long argued they are driven primarily by research, while critics charge that marketing and profits are their primary concerns. There were extensive U.S. government reviews of the pharmacy business in the 1950s and '60s and again in the 1980s. But there hasn't been a comprehensive study of drug industry profits and spending in more than a decade.

Note: For a powerful overview of corruption in the pharmaceutical industry, click here.

Docs often write off patient side-effect concerns
2007-08-28, MSNBC
http://www.msnbc.msn.com/id/20479490

When patients feel they might be having an adverse drug effect, doctors will very often dismiss their concerns, a new study shows. In a survey of 650 patients taking cholesterol-lowering drugs called statins, who reported having adverse drug reactions, many said their physicians denied that the drug could be connected to their symptoms, Dr. Beatrice A. Golomb of the University of California at San Diego ... found. “Physicians seem to commonly dismiss the possibility of a connection,” Golomb [said]. “This seems to occur even for the best-supported adverse effects of the most widely prescribed class of drugs. Clearly there is a need for better physician education about adverse effects, and there is a strong need for patient involvement in adverse event reporting.” The best-known side effects of statins ... are liver damage and muscle problems, although statins have also been tied to changes in memory, concentration and mood. Physician reaction to a potential side effect is crucial because the muscle problems can progress to a rare but potentially fatal condition called rhabdomyolysis if the drug isn’t discontinued. The researchers investigated the response of doctors to statin patients who believed they were having adverse drug reactions. In the great majority of cases, the patient, not the doctor, initiated the discussion. Forty-seven percent of patients with muscle problems or cognitive problems said their doctors dismissed the possibility that their symptoms were statin-related, while 51 percent of patients with peripheral neuropathy, a type of nerve pain affecting the extremities, said their doctors denied a possible connection with statins.

Note: For a hard-hitting overview of medical corruption, click here.

Surgeon General Sees 4-Year Term as Compromised
2007-07-10, New York Times
http://www.nytimes.com/2007/07/11/washington/11surgeon.html?ex=1341806400&en=...

Former Surgeon General Richard H. Carmona told a Congressional panel Tuesday that top Bush administration officials repeatedly tried to weaken or suppress important public health reports because of political considerations. The administration, Dr. Carmona said, would not allow him to speak or issue reports about stem cells, emergency contraception, sex education, or prison, mental and global health issues. Top officials delayed for years and tried to “water down” a landmark report on secondhand smoke, he said. Released last year, the report concluded that even brief exposure to cigarette smoke could cause immediate harm. Dr. Carmona said he was ordered to mention President Bush three times on every page of his speeches. He also said he was asked to make speeches to support Republican political candidates and to attend political briefings. Dr. Carmona is one of a growing list of present and former administration officials to charge that politics often trumped science within what had previously been largely nonpartisan government health and scientific agencies. On issue after issue, Dr. Carmona said, the administration made decisions about important public health issues based solely on political considerations, not scientific ones. “I was told to stay away from those because we’ve already decided which way we want to go,” Dr. Carmona said. He described attending a meeting of top officials in which the subject of global warming was discussed. The officials concluded that global warming was a liberal cause and dismissed it, he said.

Study suggests cancer risk from depleted uranium
2007-05-08, The Guardian
http://www.guardian.co.uk/medicine/story/0,,2074419,00.html

Depleted uranium, which is used in armour-piercing ammunition, causes widespread damage to DNA which could lead to lung cancer, according to a study of the metal's effects on human lung cells. The study adds to growing evidence that DU causes health problems on battlefields long after hostilities have ceased. DU is a byproduct of uranium refinement for nuclear power. It is much less radioactive than other uranium isotopes, and its high density - twice that of lead - makes it useful for armour and armour piercing shells. It has been used in conflicts including Bosnia, Kosovo and Iraq and there have been increasing concerns about the health effects of DU dust left on the battlefield. In November, the Ministry of Defence was forced to counteract claims that apparent increases in cancers and birth defects among Iraqis in southern Iraq were due to DU in weapons. Prof Wise and his team believe that microscopic particles of dust created during the explosion of a DU weapon stay on the battlefield and can be breathed in by soldiers and people returning after the conflict. Once they are lodged in the lung even low levels of radioactivity would damage DNA in cells close by. "The real question is whether the level of exposure is sufficient to cause health effects. The answer to that question is still unclear," he said, adding that there has as yet been little research on the effects of DU on civilians in combat zones. "Funding for DU studies is very sparse and so defining the disadvantages is hard," he added.

Note: We suspect a major cover-up of the dangers of DU, on which the media have reported little. How convenient that this pesky waste product from nuclear power plants which is radioactive for thousands of years could be sold to the military for weapons. For lots more on this vital topic, click here.

New fears over additives in children's food
2007-05-08, The Guardian
http://www.guardian.co.uk/frontpage/story/0,,2074349,00.html

Food safety experts have advised parents to eliminate a series of additives from their children's diet while they await the publication of a new study that is understood to link these ingredients to behaviour problems in youngsters. The latest scientific research into the effect of food additives on children's behaviour is thought to raise fresh doubts about the safety of controversial food colourings and a preservative widely used in sweets, drinks and processed foods. It will be several months before the results are published, despite the importance of the findings for children's health. Researchers at Southampton University have tested combinations of synthetic colourings and preservative that an average child might consume in a day to measure what effect they had on behaviour. A source at the university [said] their results supported findings first made seven years ago that linked the additives to behavioural problems, such as temper tantrums, poor concentration and hyperactivity, and to allergic reactions. Independent experts say that consumers should consider removing these additives from their children's diets now. Dr Alex Richardson, the director of Food and Behaviour Research and senior research scientist at Oxford University, said: "There are well-documented potential risks from these additives. In my view the researchers had done an excellent piece of work first time round and there was enough evidence to act. If this new study essentially replicates that, what more evidence do they need to remove these additives from children's food and drink?"

Note: For how drug companies collude with government to suppress this kind of information, click here.

Florida Man Invents Machine To Cure Cancer
2007-02-27, WPFB-TV (ABC affiliate in Palm Beach, FL)
http://www.wpbf.com/health/11125485/detail.html

A Florida man with no medical training has invented a machine that he believes may lead to a cure for cancer. John Kanzius ... wondered if his background in physics and radio could come in handy in treating the disease from which he suffers himself. After 24 rounds of chemotherapy, the former broadcaster decided that he did not want to see others suffer trying to cure the disease. Kanzius said it was watching kids being treated that affected him the most. "Particularly, young children walk in with smiles, and then you'd see them three weeks later and their smiles had disappeared. I said to myself, 'We're in a barbaric type of medicine." Kanzius said his machine basically makes cells act like antennae to pick up a signal and self-destruct. Unlike current cancer treatment, Kanzius' machine does not use radiation, and unlike today's radio-frequency treatments, it's noninvasive. Now, some of the nation's most prominent doctors and scientists are using Kanzius' machines in their research. In January, researchers said they performed a breakthrough at the M. D. Anderson Cancer Center in Houston. "The complete killing of pancreatic cells in laboratory conditions is encouraging," Dr. Steve Curley said. Kanzius explained that his machine uses a solution filled with nanoparticles, which measure no more than one-billionth of a meter. A test subject would be injected with either gold or carbon nanoparticles, which would make their way through the body and attach to the cancerous cells. The test subject would then enter the machine and receive a dose of radio frequency waves, theoretically heating and killing the cancerous cells in moments and leaving nearby cells untouched.

Note: For more on this exciting machine and the man behind it, click here. For other major media articles relating potential cancer cures, click here.

Nicotine boost was deliberate, study says
2007-01-18, Boston Globe
http://www.boston.com/news/local/articles/2007/01/18/nicotine_boost_was_delib...

Data supplied by tobacco companies strongly suggest that in recent years manufacturers deliberately boosted nicotine levels in cigarettes to more effectively hook smokers, Harvard researchers conclude in a study being released today. The companies increasingly used tobacco richer in nicotine and made design changes to give smokers more puffs per cigarette, according to the analysis from the Harvard School of Public Health. The report expands on a landmark Massachusetts Department of Public Health study issued last August showing that the amount of nicotine that could be inhaled from cigarettes increased an average of 10 percent from 1998 through 2004. A 1996 state law required cigarette makers to test the nicotine that could be inhaled from their products, and the state ordered the use of machines that simulate a typical smoker's puffing. The Harvard researchers, who corroborated the basic findings of the state study, wanted to determine why cigarettes were delivering more nicotine. "Industry says it's changed," said Greg Connolly, an author of the Harvard study. "They've changed -- maybe for the worse." The Harvard study relies on information supplied by the industry. "It was systematic, it was pervasive, it involved all the manufacturers, and it was by design," said Dr. Howard Koh, an associate dean at the Harvard School of Public Health and an author of the study. Another author said that the likelihood that the nicotine increase happened by chance was less than 1 in 1,000.

FDA May Clear Cloned Food, But Public Has Little Appetite
2006-12-25, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2006/12/24/AR20061224005...

Consumer advocates and others have complained bitterly in recent years that the Food and Drug Administration has veered from its scientific roots. Later this week, the agency is expected to release a formal recommendation that milk and meat from cloned animals should be allowed on grocery store shelves. The long-awaited decision comes as polling data to be released this week show that the public continues to have little appetite for such food, with many people saying the FDA should keep it off the market. That raises the issue: Should decisions such as this one be based solely on science, or should officials take into account public sensitivities, which may be unscientific but are undeniably real? "There is more to this issue than just food safety," said Susan Ruland of the International Dairy Foods Association, which represents such major companies as Kraft Foods and Dannon. The organization's member companies are concerned that sales of U.S. dairy products could drop by 15 percent or more if the FDA allows the sale of meat and milk from clones. Relatively few cloned farm animals exist; there are an estimated 150 clones out of the nation's 9 million dairy cows. But biotechnology companies are gearing up to clone farmers' tastiest cattle and pigs and most productive dairy cows. In the University of Maryland survey, nearly half of those polled asserted that it was not yet possible to clone farm animals for food. For the most part, people don't know this is a reality yet.

Team finds hope for diabetes cure
2006-12-15, Toronto Star (One of Canada's leading newspapers)
http://www.thestar.com/NASApp/cs/ContentServer?pagename=thestar/Layout/Articl...

A Toronto-led team of researchers has discovered a trigger for Type 1 diabetes, a breakthrough that has long evaded scientists and could lead the way to preventing the disease. The team found that abnormal nerve endings in the insulin-producing cells of the pancreas initiated a chain of events that caused Type 1 diabetes in mice. When they removed the nerve cells, the mice did not develop the disorder. That means diabetes may be a disease of the nervous system, not just an autoimmune disease, said Dr. Hans Michael Dosch, a senior scientist at the Hospital for Sick Children and the study's main investigator. In a reversal of what they expected, the researchers also found injecting substance P — a chemical secreted by nerve cells — into mice whose islet cells were inflamed and on the way to being destroyed not only eliminated the inflammation but reversed it. "The blood glucose normalizes overnight and it stays low for weeks to months — this is with a single shot," Dosch said. "We now have 4-month-old mice that are non-diabetic that used to be diabetic" — a period equivalent to six to eight years in humans. Experts say the findings, reported yesterday in the journal Cell, will change the way scientists think about diabetes. "It really is a breakthrough for the diabetes community," said Pam Ohashi, a professor of immunology at the University of Toronto. Dosch has immediate plans to move his research from mice to humans. He is launching a clinical trial in January to figure out if patients who have a high risk of Type 1 diabetes have the same sensory nerve abnormalities. "If they do, then we have fantastic new therapeutic strategies," said Dosch, who is also a professor of pediatrics and immunology at U of T.

Note: The pharmaceutical industry makes huge profits from diabetics. Big profits have been known to prevent cures from making it to market. Click here for more. Let's hope this important research moves forward.

Why do some with HIV not get sick?
2006-08-17, MSNBC News
http://msnbc.msn.com/id/14392345/

As many as one in 300 HIV patients never get sick and never suffer damage to their immune systems and AIDS experts said on Wednesday they want to know why. Most have gone unnoticed by the top researchers, because they are well, do not need treatment and do not want attention, said Dr. Bruce Walker of Harvard Medical School. But Walker and colleagues want to study these so-called "elite" patients in the hope that their cases can help in the search for a vaccine or treatments. So far Walker and colleagues have not been able to find out why certain people can live for 15 years and longer with the virus and never get ill. The AIDS virus usually kills patients within two years if they are not treated. Walker has tracked down 200 elite patients and has now joined up with other prominent AIDS researchers to find at least 1,000 "elites" in North America and as many as possible globally.

Donations tie drug firms and nonprofits
2006-05-28, Philadelphia Inquirer (Philadelphia's leading newspaper)
http://www.philly.com/mld/inquirer/living/health/14687073.htm

The American Diabetes Association...privately enlisted an Eli Lilly & Co. executive to chart its growth strategy. The National Alliance on Mental Illness...lobbies for treatment programs that also benefit its drug-company donors. The National Gaucher Foundation...gets nearly all its revenue from one drugmaker, Genzyme Corp. Many patient groups and drug companies maintain close, multimillion-dollar relationships while disclosing limited or no details about the ties. An Inquirer examination of six groups, each a leading advocate for patients in a disease area, found that the groups rarely disclose such ties when commenting or lobbying about donors' drugs. Combined, the six received at least $29 million from drug companies last year. The amount ranged from 2 percent to 7 percent of revenue at the Arthritis Foundation, to 89 percent to 91 percent at the much smaller National Gaucher Foundation. The funding usually comes from the companies' marketing or sales divisions, not charity offices. Grants often rise with promotional spending as a drug hits the market and fall when sales ebb. Donations from Merck and Pfizer Inc. to the Arthritis Foundation more than doubled, to at least $1.65 million combined, in 2000 as they launched Vioxx and Celebrex. Merck explicitly wove the foundation into sales strategies. In 2000-2001, the American Diabetes Association did not disclose an unusual gift from Lilly: a lent executive, Emerson "Randy" Hall Jr., who moved into its Alexandria, Va., headquarters and coached it on growth strategies, all paid by Lilly.

Note: If you want to understand how the huge pharmaceutical industry influences what you know about their drugs, this article is a must read. You may first want to read a riveting two-page summary of an exposé by the former editor-in-chief of the New England Journal of Medicine, who details major collusion and corruption in the pharmaceutical industry at http://www.WantToKnow.info/healthcoverup

The healing power of placebos
2006-05-01, Ode Magazine
http://www.odemagazine.com/article.php?aID=4294

A sugar pill, a salt solution, a doctor in a white jacket -- these all have the power to cure as long as the patient believes in their healing qualities. That seems impossible. So what does science say about the elusive placebo effect? Very little research has been done in this area of medicine. The pharmaceutical industry can’t profit; after all, they can’t make money from sugar pills. It is often forgotten that the effect could help people and shave billions off spiralling health-care costs. If researchers could gain more insight into how the effect works, it would stand as one of the biggest medical breakthroughs in history. Some people are convinced that the effect proves that strength of mind is sufficient to heal the body. Placebos have...proven successful in treating depression, anxiety, stress, warts and ulcers -- sometimes in as many as 60 to 70 percent of the cases. There are...objective effects everyone can measure. Placebo treatments have been shown to lower blood pressure and cholesterol levels as well as improve reaction speeds, pulse rates and immune-system activity. Ultimately, the placebo phenomenon points to a strange paradox in modern medical science. As soon as an alternative-health treatment proves successful, it is dismissed as the placebo effect. It works only because people believe in it. Yet this explanation appears to contradict one of the foundations of medical science, which stresses that the mind and body are separate, therefore ruling out the possibility of healing through belief.

Note: For ideas on why the placebo effect has rarely been studied, see our two-page health cover-up summary at http://www.WantToKnow.info/healthcoverup

Researchers Shed More Light on Bird Flu
2006-03-23, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2006/03/22/AR20060322020...

Two research teams have independently discovered explanations for the chief features of the H5N1 bird flu virus -- its difficulty infecting humans, and the deadly effects when it does. Unlike influenza viruses that are passed easily between people, H5N1 has a hard time attaching to cells in the nose, throat and upper airways. But it readily attaches to cells deep in the lungs. This suggests that people need close and heavy exposure to the H5N1 virus for it to get into the lungs.

Note: Yet governments have already spent many millions of dollars stockpiling Tamiflu believing that avian flu will mutate and cause a pandemic killing millions. And top government officials have already made many millions of dollars on stocks related to Tamiflu--the drug designed to combat a deadly virus which hasn't even mutated yet to know if the drug works! Remember that generating fear in the public is one of the best ways to make a profit. For lots more, click here.

Chiron Gets Contract for Bird Flu Vaccine
2005-10-27, ABC/Associated Press
http://abcnews.go.com/Health/wireStory?id=1256959

A second manufacturer is beginning mass production of a vaccine to protect against bird flu, and the Senate moved Thursday to invest far more -- $8 billion -- on preparations in case the influenza strain ever sparks a worldwide epidemic. Before the Senate acted, Health and Human Services Secretary Mike Leavitt awarded a $62.5 million contract to Emeryville, Calif.-based Chiron Corp. to manufacture bird flu vaccine. Sanofi-Aventis of Paris began manufacturing $100 million worth of a similar vaccine last month. The Bush administration is putting the final touches on its plan for how to fight the next super-flu...amid growing concern that the H5N1 influenza strain spreading among birds from Asia to Europe could trigger a pandemic if it mutates into a form easily spread from person to person. The massive out-of-budget expenditure...would increase stockpiles of the antiviral drugs Tamiflu and Relenza, thought to be effective against current strains of bird flu. "The money that we spend now will not be wasted even if this particular strain of the virus, H5N1, ends up not becoming a pandemic flu," said Sen. Barack Obama, D-Ill. "We know that over the next two, three decades there will be a pandemic flu. That's almost certain."

Note: If the above link fails, click here. Isn't is interesting that over $60 million dollars (potentially $8 billion!) has been "awarded" for a vaccine against a bird flu that hasn't even mutated yet? How are these people so certain that it will mutate and kill millions of people? How do we know these vaccines will work when it hasn't even mutated? Note also that the pharmaceutical industry, which manufactures vaccines, has the largest lobby in all Washington and is raking in huge profits. For lots more on this, don't miss the vital information in our Health Information Center.

A Serious Drug Problem
2005-05-06, New York Times
http://www.nytimes.com/2005/05/06/opinion/06krugman.html

Note: The following is the New York Times website's abstract of this article, which is a very good summary.

2003 Medicare bill is object lesson in how special interests hold America's health care system hostage; says law subsidizes private health plans, which have repeatedly failed to deliver promised cost savings, and creates unnecessary layer of middlemen by requiring that drug benefit be administered by private insurers; says it specifically prohibits Medicare from using its purchasing power to negotiate lower drug prices; notes that Rep Billy Tauzin, who shepherded drug bill through Congress, now heads all-powerful drug-industry lobbying group, and Thomas Scully, former Medicare administrator, negotiated for future health industry lobbying job at same time he was pushing drug bill; calls Medicare bill corrupt deal created by corrupt system.

Cold virus may be skin cancer cure
2004-01-07, CNN News
http://www.cnn.com/2004/HEALTH/01/07/australia.skincancer

Researchers at an Australian university believe they have developed a breakthrough showing skin cancer can be stopped by the common cold virus. Skin cancer, or melanoma, is the fifth most common form of cancer. Australia has the highest rate of melanoma in the world, with one out of every two people likely to develop some form of the disease during their lifetime. A team led by Professor Darren Shafren at the University of Newcastle, about 150 kilometers north of Sydney, have established that malignant melanoma cells can be destroyed by infecting them with coxsackievirus, the common cold virus. "We believe this is a significant breakthrough in the development of the treatment of melanoma," Dr Shafren said in a statement released by the university Wednesday. He said the results achieved so far using human cells and in animal studies had been "very exciting". "If we can replicate that success in human trials, the treatment of this often fatal disease could be available within the next few years," he said. According to the university researchers, the projected process begins by injecting the common cold virus into a melanoma. The virus replicates itself and then, according to the projection, begins killing off the melanoma. Within weeks, there is a reduction in the size of the melanoma and it eventually disappears. Dr Shafren noted that the coxsackievirus was not a manufactured drug or a genetically altered virus. Instead, it was a virus that occurred in the community.

Note: Why wasn't this exciting development put on the fast track and lots of money pored in to develop it quickly. Could it be that this cancer treatment would negatively impact the huge profits of the drug companies? For more reliable information on this, click here.

LSD's long, strange trip back into the lab
2009-09-27, San Francisco Chronicle (San Francisco's leading newspaper)
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2009/09/27/MNEN19SNGD.DTL

LSD, the drug that launched the psychedelic era and became one of the resounding symbols of the counterculture movement of the '60s, is back in the labs. Nearly 40 years after widespread fear over recreational abuse of LSD and other hallucinogens forced dozens of scientists to abandon their work, researchers at a handful of major institutions - including UCSF and Harvard University - are reigniting studies. The study at UCSF ... is looking into the mechanisms of LSD and how it works in the brain. The hope is that such research might support further studies into medical applications of LSD - for chronic headaches, for example - or psychiatric uses. "Psychedelics are in labs all over the world and there's a lot of promise," said Rick Doblin, director of the Multidisciplinary Association for Psychedelic Studies in Santa Cruz. Stanislav Grof was one of the last scientists to abandon hallucinogenic research when he shut down several projects at the Maryland Psychiatric Research Center in 1973 after his funding dried up. He moved to California to work at a research institute in Big Sur, where he turned to studies about how to re-create the effects of those drugs through meditation and breathing techniques. He's pleased to see some of the stigma falling away from drugs like LSD, but it bothers him that the scientific community lost decades of research. "I thought psychiatry and psychology really lost a major opportunity because of the abuse that happened with unsupervised research," Grof said. "These are fascinating substances - and they're very, very powerful, so they should be used with great precaution."

WHO: 3BN swine flu vaccine doses available yearly
2009-09-24, Forbes.com/Associated Press
http://www.forbes.com/feeds/ap/2009/09/24/general-un-who-swine-flu_6927291.html

Pharmaceutical companies will be able to produce about 3 billion doses of swine flu vaccine a year ... the World Health Organization said. The U.N. agency had previously predicted that companies would be able to make up to 5 billion doses each year. The World Health Organization admits that not everyone may need vaccination. "Most people will do well without the vaccine," WHO vaccine chief Marie-Paule Kieny told reporters. She said most people infected with the pandemic strain of the H1N1 virus have a mild illness and recover by themselves. Addressing concerns about the safety of the pandemic vaccine, WHO said trials to date suggest it is as safe as a regular seasonal flu shot. Kieny said large-scale vaccination programs would probably detect some cases of severe reaction following the vaccination, but that those would likely have occurred anyway without vaccination. The agency is urging countries to monitor the vaccination procedure for possible further side effects. Meanwhile WHO Director-General Dr. Margaret Chan repeated Thursday her recommendation that governments keep up their guard against swine flu but refrain from closing borders or restricting trade.

Note: With the cost of a regular flu vaccine dose ranging from about $20 to $30, do you think the pharmaceutical companies have any vested interest in the public being vaccinated? Let's see, 3 billion X $20 = $60 billion. Hmm. For more on the danger of this vaccine and rampant fear mongering, click here and here.

The Five Biggest Lies in the Health Care Debate
2009-08-29, Time magazine
http://www.newsweek.com/id/214254

To the credit of opponents of health-care reform, the lies and exaggerations they're spreading are not made up out of whole cloth—which makes the misinformation that much more credible. Instead, because opponents demand that everyone within earshot (or e-mail range) look, say, "at page 425 of the House bill!," the lies take on a patina of credibility. Take the claim in one chain e-mail that the government will have electronic access to everyone's bank account, implying that the Feds will rob you blind. The 1,017-page bill passed by the House Ways and Means Committee does call for electronic fund transfers—but from insurers to doctors and other providers. There is zero provision to include patients in any such system. Five other myths that won't die: [1] You'll have no choice in what health benefits you receive. [2] No chemo for older Medicare patients. A related myth is that health-care reform will be financed through $500 billion in Medicare cuts. This refers to proposed decreases in Medicare increases. [3] Illegal immigrants will get free health insurance. [4] Death panels will decide who lives. [5] The government will set doctors' wages. To be sure, there are also honest and principled objections to health-care reform. Some oppose a requirement that everyone have health insurance as an erosion of individual liberty. And many are simply scared out of their wits about what health-care reform will mean for them. But when fear and loathing hijack the brain, anything becomes believable.

Note: For lots more on health issues from major media sources, click here.

previous

...10111213141516171819...

next

· entire list